Starcom wins 999 Pharmaceuticals

GUANGZHOU - Starcom has won the China planning and buying account for Shenzhen-based 999 Pharmaceuticals, after a two month long pitch against two other agencies.

999 Pharmaceuticals is mainly focused in the highly competitive Chinese traditional medicine market, and specialises in cold and cough remedies.

The estimated billings are in excess of US$41million.